SCHEMBL2780732

SCHEMBL2780732

CC(NC(=O)O)[C@@H](OCc1ccccc1)OS(C)(=O)=O

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SLC1A3 P43003 2/20 0.41
SLC1A2 P43004 2/20 0.41
SLC1A1 P43005 2/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
MMP9 P14780 2/20 0.40
MMP8 P22894 2/20 0.40
PSMB5 P28074 1/20 0.39
ADAMTS4 O75173 1/20 0.38
MMP13 P45452 1/20 0.38
NPC1 O15118 1/20 0.38
RAB9A P51151 1/20 0.38
ATM Q13315 1/20 0.38
ALDH1A1 P00352 1/20 0.37
LMNA P02545 1/20 0.37
CA12 O43570 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20551984 0.77 PSMB5 (0.47) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL15716272 0.77 PSMB5 (0.47) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL4973401 0.76 MMP9 (0.44) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL4190909 0.75 CA1 (0.43) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL4769827 0.75 MMP9 (0.48) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL12493209 0.74 MMP9 (0.43) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL9045544 0.74 SLC1A3 (0.39) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL19597242 0.73 CA1 (0.42) SLC1A3SLC1A2SLC1A1MEN1KMT2A
SCHEMBL3949229 0.72 ATM (0.54) ATMCA12CA1CA2CA9
SCHEMBL9013134 0.71 HPGD (0.45) SLC1A3SLC1A2SLC1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010091104-A1 GLUCOSYLCERAMIDE SYNTHASE INHIBITORS EXELIXIS, INC. (US) 2010-08-12 WO disclosed